Nowadays, molecular markers are increasingly applied for further characterization of gliomas aside from the WHO tumor grades.3 Consequently, we plan to correlate the heme biosynthesis mRNA expression signature with specific molecular markers such isocitrate dehydrogenase (IDH) mutations, 1p/19q co-deletion and p53 mutation in the next step. The gene discussed is TP53; the disease is neoplasm.